Lv11
60 积分 2025-07-29 加入
Serum Thyroglobulin Doubling Time in Progressive Thyroid Cancer
7小时前
已完结
Lesional dosimetry in 131I refractory metastatic differentiated thyroid cancer with BRAFp.V600E or RAS mutation treated with trametinib +/- dabrafenib followed by radioactive iodine
1个月前
已完结
BalakirouchenaneD,SebanR,GroussinL,etal.Pharmacokinetics/pharmacodynamics of dabrafenib andtrametinib for redifferentiation and treatment of radioactiveiodine-resistant mutated advanced differentiated thyroidcancer
1个月前
已完结
Tumor response and thyroglobulin change in differentiated thyroid carcinoma treated with dabrafenib plus trametinib
1个月前
已完结
Feasibility of Short-Term Redifferentiation in Patients with Radioactive Iodine-Refractory Metastatic Thyroid Cancer
1个月前
已完结
Recombinant or endogenous thyroid-stimulating hormone for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies
10个月前
已完结
Response to RL‐225Ac in prostate cancer: Effect of prior treatment with RL‐177Lu: A systematic review of the literature
1年前
已完结
皖公网安备34019202002308
